GI
RDY icon

GAMMA Investing’s Dr. Reddy's Laboratories RDY Stock Holding History

GAMMA Investing’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$76.7K Sell
6,079
-8,843
-59% -$110K ﹤0.01% 2071
2026
Q2 		$216K Buy
14,922
+1,991
+15% +$26.9K 0.01% 1217
2026
Q1 		$179K Buy
12,931
+3,360
+35% +$46.8K 0.01% 1205
2025
Q4 		$134K Sell
9,571
-1,276
-12% -$17.9K 0.01% 1349
2025
Q3 		$152K Sell
10,847
-352
-3% -$5.07K 0.01% 1179
2025
Q2 		$168K Buy
11,199
+5,676
+103% +$81.1K 0.01% 1037
2025
Q1 		$72.8K Sell
5,523
-1,276
-19% -$17.6K 0.01% 1509
2024
Q4 		$107K Sell
6,799
-436
-6% -$6.55K 0.01% 1066
2024
Q3 		$115K Buy
7,235
+3,285
+83% +$52.9K 0.01% 911
2024
Q2 		$60.2K Buy
3,950
+345
+10% +$4.95K 0.01% 1065
2024
Q1 		$52.9K Buy
3,605
+1,275
+55% +$18.6K 0.01% 1008
2023
Q4 		$33.5K Buy
+2,330
New +$31.2K 0.01% 1160

Other funds holding RDY

CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GAMMA Investing's RDY Position: Q3 2026 in Review

GAMMA Investing reduced its Dr. Reddy's Laboratories (RDY) stake by 59% in Q3 2026, selling an estimated $110K and leaving 6,079 shares worth $76.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2071.

GAMMA Investing first reported a position in RDY in Q4 2023 and has held it in 12 quarters since. The position peaked at $216K in Q2 2026. 5 funds tracked by Wall St. Rank hold RDY as of Q3 2026.

  • GAMMA Investing held 6,079 shares of Dr. Reddy's Laboratories worth $76.7K as of Q3 2026.
  • GAMMA Investing sold 8,843 Dr. Reddy's Laboratories shares in Q3 2026, an estimated $110K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2071 holding.
  • GAMMA Investing first reported a position in Dr. Reddy's Laboratories in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Dr. Reddy's Laboratories position peaked at $216K in Q2 2026.
  • 5 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.